pH-responsive iron-loaded carbonaceous nanoparticles for chemodynamic therapy based on the Fenton reaction-Reference-Cited by-同舟云学术

pH-responsive iron-loaded carbonaceous nanoparticles for chemodynamic therapy based on the Fenton reaction

Published:2024 Issue:16 Volume:12 Page:3959-3969
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li Nianlu¹²,Zhang Gaorui³⁴,Zhan Jinhua¹^ORCID,Yu Dexin³⁴^ORCID

Affiliation:

1. School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China

2. Physical and Chemical Laboratory, Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China

3. Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China

4. Translational Medicine Research Center in Nano Molecular and Functional Imaging of Shandong University, Jinan, 250100, China

Abstract

Iron-loaded carbonaceous nanoparticles with enhanced Fenton catalytic activity through carbonaceous nanoparticle-mediated electron transfer for chemodynamic therapy for cancer.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB02875E

Reference49 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Recent progress in nanomedicine for enhanced cancer chemotherapy

3. Mito‐Bomb: Targeting Mitochondria for Cancer Therapy

4. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

5. Targeting Tumor Microenvironment for Cancer Therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism;Colloids and Surfaces B: Biointerfaces;2024-12